Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Praluent
Praluent
Regeneron to Slash Price of Cholesterol Drug After Showing it Saved Lives
Xconomy
Sat, 03/10/18 - 09:12 am
Regeneron
cholesterol
drug pricing
Sanofi
Praluent
The Moment Of Truth Is Coming For Struggling And Expensive Cholesterol Drugs
Forbes
Sun, 02/18/18 - 10:16 am
cholesterol
PCSK9 inhibitors
Sanofi
Regeneron
Praluent
Amgen
Repatha
PCSK9 court saga drags on for Sanofi, Regeneron and Amgen
Biopharma Dive
Mon, 10/9/17 - 09:36 am
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
Praluent
Repatha
U.S. court reverses ban on sale of Sanofi, Regeneron drug Praluent
Yahoo/Reuters
Thu, 10/5/17 - 11:46 am
Sanofi
Regeneron
Praluent
Repatha
patents
Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients
Fierce Pharma
Mon, 09/18/17 - 11:08 am
Sanofi
Amgen
PCSK9 inhibitors
diabetes
Regeneron
Praluent
Repatha
Insurers, doctors battle over new heart disease drugs
CNBC
Fri, 09/8/17 - 09:30 am
insurers
cardiovascular disease
statins
PCSK9 inhibitors
Amgen
Regeneron
Sanofi
Repatha
Praluent
In cost debate, Amgen stands by Repatha's value
BioPharma Dive
Wed, 08/23/17 - 11:36 am
Amgen
Repatha
drug pricing
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Regeneron’s Praluent May See Gradual Increase in 2017 Demand
Market Realist
Tue, 06/20/17 - 09:31 am
Regeneron
Praluent
Sanofi
Sanofi and Regeneron's Praluent safely smacks LDL in high-risk diabetics
Fierce Pharma
Mon, 06/12/17 - 09:42 am
Sanofi
Regeneron
Praluent
diabetes
LDL cholesterol
Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent® (alirocumab) Injection
Yahoo
Tue, 04/25/17 - 11:04 am
Sanofi
Regeneron
FDA
Praluent
3 Big Biotech Stocks With Big-Time Catalysts
Motley Fool
Sun, 04/9/17 - 12:36 pm
Regeneron
Praluent
Amgen
biosimilars
Amjevita
Humira
ABP-215
Avastin
ABP-980
Herceptin
Celgene
ozanimod
Sanofi confident in case to overturn Praluent ban
BioPharma Dive
Sat, 02/11/17 - 12:47 pm
Sanofi
Praluent
Regeneron
Amgen
Repatha
Sanofi, Regeneron win a crucial stay of execution on Praluent
Endpoints
Wed, 02/8/17 - 09:36 pm
Sanofi
Regeneron
Praluent
Amgen
Repatha
When it comes to PCSK9s, payers resisted — and sales flopped
Medical Marketing and Media
Wed, 01/11/17 - 09:54 am
PCSK9 inhibitors
payers
Amgen
Sanofi
Regeneron
Repatha
Praluent
Regeneron CEO says Amgen not putting patients first in patent dispute
Yahoo/Reuters
Tue, 01/10/17 - 09:19 am
Regeneron
Pharma CEOs
Amgen
Sanofi
patents
Repatha
Praluent
Len Schleifer
Judge’s unusual ruling on Amgen, Regeneron patent case puts billions of dollars at stake
Marketwatch
Sun, 01/8/17 - 03:32 pm
Amgen
Sanofi
Regeneron
Repatha
Praluent
Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection
Yahoo
Fri, 01/6/17 - 10:22 am
Regeneron
Sanofi
Amgen
patents
Repatha
Praluent
Amgen Wins Ban on Sanofi’s Praluent Cholesterol Drug Sales
Bloomberg
Fri, 01/6/17 - 09:51 am
Amgen
Sanofi
Regeneron
Praluent
Repatha
patents
Sanofi, Regeneron one step closer to owing PCSK9 royalties as judge upholds Amgen patent ruling
Fierce Pharma
Thu, 01/5/17 - 09:20 am
Sanofi
Regeneron
PCSK9 inhibitors
Amgen
Praluent
Repatha
Amgen, Regeneron May Yet Get Rich From Their Cholesterol Drugs
Seeking Alpha
Tue, 12/20/16 - 12:04 pm
Amgen
Regeneron
Praluent
Repatha
Sanofi
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »